Search Results - "Giatra, H."

PF297 COMPARISON OF RITUXIMAB DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) WITH RITUXIMAB‐CHOP (R‐CHOP) CHEMOTHERAPY IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL) by Vassilakopoulos, T., Mellios, Z., Verigou, E., Papageorgiou, S., Chatzidimitriou, C., Giatra, H., Kalpadakis, C., Gainaru, G., Karakatsanis, S., Xanthopoulos, V., Katrodritou, E., Tsirogianni, M., Arapaki, M., Giannikos, T., Katsaouni, P., Assimakopoulos, I., Liaskas, A., Constaninou, E., Bellia, M., Kourti, G., Leonidopoulou, T., Assimakopoulou, T., Karianakis, G., Symeonidis, A., Grentzelias, D., Sakellariou, K., Pappa, V., Papadaki, E., Plata, E., Bakiri, M., Angelopoulou, M., Konstantopoulos, K., Karmiris, T.

“…Background: R‐da‐EPOCH provided excellent results in PMLBCL in a phase 2 NCI trial and appeared to obviate the need for consolidative radiotherapy (RT)…”
Get full text

PS1089 PET‐SCAN FOR RESPONSE ASSESSEMENT AFTER RITUXIMAB‐DOSE‐ADJUSTED‐EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): CLINICAL AND PROGNOSTIC SIGNIFICANCE by Vassilakopoulos, T., Chatzidimitriou, C., Mellios, Z., Verigou, E., Papageorgiou, S., Giatra, H., Kalpadakis, C., Gainaru, G., Karatsanis, S., Xanthopoulos, V., Koumarianou, A., Katodritou, E., Tsirogianni, M., Arapaki, M., Giannikos, T., Efstathopoulou, M., Karanakis, G., Simeonidis, A., Grentzelias, D., Sakellariou, K., Papadaki, E., Plata, E., Bakiri, M., Datseris, I., Chatziioannou, S., Prassopoulos, V., Konstantopoulos, K., Angelopoulou, M., Themistoklis, K., Rontogianni, P.

“…Background: PET‐scan has been evaluated in PMLBCL regarding its prognostic significance under R‐CHOP and R‐MACOP‐B chemotherapy. Patients with clearly positive…”
Get full text

PF472 VERY LATE REALAPSES (VLR) ≥5 YEARS AFTER INITIAL TREATMENT WITH CHEMOTHERAPY±RADIOTHERAPY (CT±RT) IN HODGKIN LYMPHOMA (HL): A JOIN STUDY ON TREATMENT STRATEGIES AND PROGNOSTIC FACTORS FOR THE OUTCOME by Vassilakopoulos, T., Liaskas, A., Rizzuto, G., Angelopoulou, M., Giatra, H., Kontopidou, F., Dimopoulou, M., Musseti, A., Siakantari, M., Asimakopoulos, I., Arapaki, M., Triantafyllou, F., Chatzidimitriou, C., Yannikos, T., Korkolopoulou, P., Cabras, A., Rassidakis, G., Dimou, M., Variami, E., Panagiotidis, P., Corradini, P., Bakiri, M., Karmiris, T., Konstantopoulos, K., Pangalis, G., Viviani, S.

“…Background: Risk‐adapted treatment strategies have improved the long‐term outcome of patients with Hodgkin Lymphoma (HL) and traditionally the disease is…”
Get full text